Aastrom Biosciences receives delisting letter from Nasdaq for not remaining in compliance

Full story: KTLA-TV Los Angeles

Aastrom Biosciences Inc., which develops stem cell therapies, said Wednesday it received a notice saying it might be subject to delisting from the Nasdaq.

Read

2 Comments

Add to my Tracker

More Aastrom Biosciences Discussions »

Email me Aastrom Biosciences news. Learn more

Comments

Showing posts 1 - 2 of2

lois

AOL

We need astm. If you listen to the news this week there were 3 surgeries done with stem cell. Cheekbones, facelift filler, and neck surgery. Come on stem cell is here and now. FDA needs to approve It here. We could all save so much money on health care too and save so many lives too. Stop supporting the other countries when we can support our own. Don,t delist astm.

sol

AOL

The President needs to fund stem cell as promised. He signed the bill but never funded. I hope he stands by his word because he can be saving america and saving health care too. This is the future. Read and Educate.

Tell me when this thread is updated:
(Registration is not required)

Add to my Tracker

Send me an email

Showing posts 1 - 2 of2

Type in your comments below

Name
(appears on your post)

Comments

Characters left: 4000

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.